Side-by-side comparison of AI visibility scores, market position, and capabilities
Berlin European insurtech B2B2C platform at €800M revenue with 2M+ customers; €170M Searchlight Capital refinancing Jan 2025 after $4.5B→<$1B valuation decline with new CEO Joachim Müller (ex-Allianz) competing with Clark.
Wefox is a Berlin, Germany-based European insurtech platform — having raised $1.9 billion in total funding including a $400 million Series D in 2022 at a peak $4.5 billion valuation — operating a B2B2C insurance distribution model through a network of independent insurance brokers and advisors serving over 2 million customers across the Netherlands, Austria, Switzerland, and other European markets with €800 million in annual revenue. Founded in 2014 by Julian Teicke, Fabian Wesemann, and Dario Fazlic as FinanceFox (rebranded to Wefox in 2017 after acquiring ONE Insurance), the company positioned itself as the leading European insurtech unicorn with household, motor, personal liability, health, and life insurance products. Following financial losses and valuation decline below $1 billion, founder Julian Teicke stepped down as CEO in March 2024 after nine years. In September 2024, Joachim Müller — former CEO of Allianz Global Corporate & Specialty — was appointed CEO to lead restructuring and growth. In January 2025, Wefox secured €170 million in refinancing led by Searchlight Capital Partners, exited the German and Polish markets, and focused on profitable core markets.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.